Clinical Trials Update: Jan. 11, 2007
Constipation Rheumatoid Arthritis Neck Pain
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the safety and effectiveness of an investigational drug, linaclotide acetate, in treating chronic constipation. Volunteers at least 18 may qualify who report fewer than three spontaneous bowel movements per week. Other criteria apply.
The research sites are located throughout the United States.
This study will evaluate the effectiveness of an investigational medication in controlling symptoms of rheumatoid arthritis when taken in addition to methotrexate. Candidates at least 18 who have active rheumatoid arthritis, are taking 10 mg to 25 mg of methotrexate per week, and have at least six tender joints and at least six swollen joints may be eligible.
The research sites are located across the United States.
This study will evaluate the effectiveness the Lidoderm 5% Topical Patch in treating pain and dysfunction in people with cervical facet joint osteoarthritis -- whiplash. Patients 18-65 who have had neck pain for at least six months and less than two years that does not extend to the arm or hand may be included. Volunteers may not have a history of bleeding ulcer, renal insufficiency or failure, gastroesophageal disease, cancer of the neck, or current skin break down around neck area.
The research site is in Stanford, Calif.
Copyright 2007 Thomson CenterWatch. All rights reserved.